2,6-di-tert-butylphenol has been researched along with gamma-aminobutyric acid in 2 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akabas, MH; Williams, DB | 1 |
| Ahrens, J; de la Roche, J; Foadi, N; Haeseler, G; Krampfl, K; Leuwer, M | 1 |
2 other study(ies) available for 2,6-di-tert-butylphenol and gamma-aminobutyric acid
| Article | Year |
|---|---|
Structural evidence that propofol stabilizes different GABA(A) receptor states at potentiating and activating concentrations.
Topics: 4-Chloromercuribenzenesulfonate; Amino Acid Substitution; Anesthetics, Intravenous; Animals; Dose-Response Relationship, Drug; Drug Synergism; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Microinjections; Mutagenesis, Site-Directed; Oocytes; Patch-Clamp Techniques; Phenols; Propofol; Protein Binding; Protein Conformation; Rats; Receptors, GABA-A; Structure-Activity Relationship; Sulfhydryl Reagents; Xenopus | 2002 |
The non-anaesthetic propofol analogue 2,6-di-tert-butylphenol fails to modulate GABA(A) receptor function.
Topics: Anesthetics, Intravenous; Animals; Cell Line; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Humans; Membrane Potentials; Patch-Clamp Techniques; Phenols; Propofol; Rats; Receptors, GABA-A; Transfection | 2009 |